1. Abrahamsson P-A, Wadstroem LB, Alumets J, Falkmer S, Grimelius L (1986) Peptide-hormone-and serotonin-immunoreactive cells in normal and hyperplastic prostate glands. Path Res Pract 181: 675
2. Adolfsson J, Carstensen J (1991) Natural course of clinically localized prostate adenocarcinoma in men less than 70 years old. J Urol 146: 96
3. Altwein JE (1982) Hormone manipulation for palliative treatment of advanced prostatic carcinoma. In: Jacobi GH, Hohenfellner R (eds): Prostate cancer. Williams & Wilkins, Baltimore-London, p. 215
4. Aprikian AG, Cordon-Cardo C, Fair WR, Reuter VE (1993) Characterization of neuroendocrine differentiation in human benign prostate and prostatic adenocarcinoma. Cancer 71: 3952
5. Bagshaw MA, Cox RS, Ray GR (1988) Status of radiation treatment of prostate cancer at Stanford University. NCI Monogr 7: 47